Perfluorooctanoic acid, perfluorooctanesulfonate, and serum lipids in children and adolescents: results from the C8 Health Project. - Wikidata - awgldk - TriplyDB

Perfluorooctanoic acid, perfluorooctanesulfonate, and serum lipids in children and adolescents: results from the C8 Health Project.

Perfluorooctanoic acid, perfluorooctanesulfonate, and serum lipids in children and adolescents: results from the C8 Health Project.

http://www.wikidata.org/entity/Q35049761

about

Epidemiologic evidence on the health effects of perfluorooctanoic acid (PFOA)Endocrine disrupting properties of perfluorooctanoic acid Overview of Emerging Contaminants and Associated Human Health Effects Modeled PFOA exposure and coronary artery disease, hypertension, and high cholesterol in community and worker cohorts Exposure to perfluoroalkyl acids and markers of kidney function among children and adolescents living near a chemical plant Association of osteoarthritis with serum levels of the environmental contaminants perfluorooctanoate and perfluorooctane sulfonate in a large Appalachian population.No association between perfluoroalkyl chemicals and hypertension in children Metabolic Profiling of Chicken Embryos Exposed to Perfluorooctanoic Acid (PFOA) and Agonists to Peroxisome Proliferator-Activated Receptors High-performance metabolic profiling of plasma from seven mammalian species for simultaneous environmental chemical surveillance and bioeffect monitoring.Loss and in situ production of perfluoroalkyl chemicals in outdoor biosolids-soil mesocosms.Associations between serum perfluoroalkyl acids and LINE-1 DNA methylation.Toxicant exposure and bioaccumulation: a common and potentially reversible cause of cognitive dysfunction and dementia Using blood gene signatures for assessing effects of exposure to perfluoroalkyl acids (PFAAs) in humans: the NOWAC postgenome study.Polyfluoroalkyl compounds in Texas children from birth through 12 years of age.The Association of Prenatal Exposure to Perfluorinated Chemicals with Maternal Essential and Long-Chain Polyunsaturated Fatty Acids during Pregnancy and the Birth Weight of Their Offspring: The Hokkaido Study.Oral perfluorooctane sulfonate (PFOS) lessens tumor development in the APCmin mouse model of spontaneous familial adenomatous polyposis.Association between plasma PFOA and PFOS levels and total cholesterol in a middle-aged Danish population.Hypercholesterolemia with consumption of PFOA-laced Western diets is dependent on strain and sex of mice Serum polyfluoroalkyl concentrations, asthma outcomes, and immunological markers in a case-control study of Taiwanese children Hepatic and renal Bcrp transporter expression in mice treated with perfluorooctanoic acid.Positive association between perfluoroalkyl chemicals and hyperuricemia in children.National inventory of perfluoroalkyl substances in archived U.S. biosolids from the 2001 EPA National Sewage Sludge Survey.Perfluoroalkyl substances and lipid concentrations in plasma during pregnancy among women in the Norwegian Mother and Child Cohort Study.The Association of Prenatal Exposure to Perfluorinated Chemicals with Glucocorticoid and Androgenic Hormones in Cord Blood Samples: The Hokkaido Study.Demographic, Reproductive, and Dietary Determinants of Perfluorooctane Sulfonic (PFOS) and Perfluorooctanoic Acid (PFOA) Concentrations in Human Colostrum A Study of Reverse Causation: Examining the Associations of Perfluorooctanoic Acid Serum Levels with Two Outcomes.The impact of PFOS on health in the general population: a review.Physiologically based pharmacokinetic modeling of human exposure to perfluorooctanoic acid suggests historical non drinking-water exposures are important for predicting current serum concentrations.Per- and polyfluoroalkyl substances in human serum and urine samples from a residentially exposed community.PPARα-independent transcriptional targets of perfluoroalkyl acids revealed by transcript profiling.Effect of high density lipoprotein cholesterol on the relationship of serum iron and hemoglobin with kidney function in diabetes.The chemical disruption of human metabolism.Exposure to Perfluorinated Alkyl Substances and Health Outcomes in Children: A Systematic Review of the Epidemiologic Literature.Recent developments in polyfluoroalkyl compounds research: a focus on human/environmental health impact, suggested substitutes and removal strategies.RNA-sequencing analysis reveals the hepatotoxic mechanism of perfluoroalkyl alternatives, HFPO2 and HFPO4, following exposure in mice.Perfluoroalkyl substances with isomer analysis in umbilical cord serum in China.Perfluorooctanoic acid-induced toxicity in primary cultures of chicken embryo cardiomyocytes.High Levels of Perfluorooctane Sulfonate in Children at the Onset of Diabetes Serum perfluoroalkyl substances and cardiometabolic consequences in adolescents exposed to the World Trade Center disaster and a matched comparison group Perfluorooctanoic acid exposure triggers oxidative stress in the mouse pancreas.

P2860

Q24632957-F31C86B8-E9C3-4B10-B3EB-6E05F58FECE4 Q24633469-4DE10D91-A92F-450E-8E1E-43873B98D083 Q26771705-7217BF17-07E3-41CA-AD9E-AEFE00C90CC9 Q28383653-D8ACB439-FA46-4E90-A755-6B28DB6DEB0D Q28383912-1B66B90A-98B0-476B-A671-E35E77EE926C Q28393054-68322D7D-8C6A-452F-9443-36E883C41BE1 Q28395753-B621EAFF-025B-4B2B-A202-1D76B0B13DD3 Q28551209-72469073-D34D-4F0C-8C4E-54291610FC70 Q30513661-43B4087B-B901-47AD-8C7B-5D7610B7F9BC Q34005377-BE3474FF-3B1C-474B-AB5B-A632B4EF9C3B Q34273620-C9126F6C-7F62-4BF8-8693-4CAB4367E401 Q35101951-51AB327F-02EB-4164-A366-F776F4F53DC9 Q35193826-AF554DCD-5FC8-4303-AA8C-81E50CAE0C2A Q35920263-B38D8458-9380-4759-AC3C-7EC9B29FA908 Q36112054-4C8FC9C9-77FE-42B0-A48C-179D13B050FC Q36215197-32322D2F-DB0C-4E2C-8831-9971E1AFA466 Q36618735-C19823AC-6BC2-4F21-9909-D4782943C566 Q36629792-B4B4D6B6-FBAA-45BE-A765-16800D9BA668 Q36751014-D3FE6150-67D0-4D50-9382-370EB4B735BB Q36819416-66363703-4992-46E7-B0CE-8A2104AA3579 Q36876519-4B54BD3C-F2DC-425B-A276-A9332EC43A3E Q37181249-CA1CFF72-9D06-42C1-9F7B-71A599F6C26F Q37408761-AE41B008-985E-4F58-B703-62486C78F21F Q37580534-177862A3-0AC4-40FA-9B86-AA977E2D7FD2 Q37600475-83B19347-46E8-4ADB-BA49-DDC2E3E11616 Q37674896-9EB72977-1FEF-4589-A35A-6148D0738AF3 Q38248164-1D732032-67BB-49D8-A55B-67ED81CA9467 Q38690520-FCC0B4E0-5810-462E-B956-E510E77CBD02 Q38711850-1A8BEA90-2CA2-417F-BAF5-5F88DA65A3E3 Q38755871-7200504A-E63B-45D4-AC73-032A922F79D2 Q38836350-11878C8A-D43A-4ACC-BEB1-588938FAB622 Q39264905-CC708590-2FB1-41E5-AA09-FE3CA6BAC5A3 Q39400487-4899ABFF-3817-4F69-9E8B-B4F45C052D96 Q39443231-87DD709B-B3EB-4FE3-9462-E8E25270A0DF Q39461300-B66C4D7D-167F-4533-8E9D-B7851AA3DE20 Q40251746-E99347FD-C793-4163-A747-37AA71C22E42 Q40811918-1A43BB70-9DC7-4D4D-876F-197DFC58FA2D Q40813892-ADF6C6B9-6BF3-4F9E-A209-9F2BE3B50886 Q41571384-F3A8A348-C810-4B55-B148-B6A83033FFB0 Q41681299-EFB66C77-5542-43D5-AB24-885C0B00E0EC

P2860

Perfluorooctanoic acid, perfluorooctanesulfonate, and serum lipids in children and adolescents: results from the C8 Health Project.

http://www.wikidata.org/entity/Q35049761

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Perfluorooctanoic acid, perflu ...... ts from the C8 Health Project.

@ast

Perfluorooctanoic acid, perflu ...... ts from the C8 Health Project.

@en

type

label

Perfluorooctanoic acid, perflu ...... ts from the C8 Health Project.

@ast

Perfluorooctanoic acid, perflu ...... ts from the C8 Health Project.

@en

prefLabel

Perfluorooctanoic acid, perflu ...... ts from the C8 Health Project.

@ast

Perfluorooctanoic acid, perflu ...... ts from the C8 Health Project.

@en

P1433

Q35049761-CF5A892D-DD36-4BA1-916E-9B3AF311BBFB

P1476

Q35049761-3A7E0212-2B15-4759-82F4-9893BA2DBDD3

P2093

Q35049761-31F63185-53CA-489A-9B08-F65FD25A7C30

Q35049761-3DE6E215-9347-4903-A2BC-4B0E769FCB48

Q35049761-7F652273-0093-4493-8884-3D4892F8CB79

Q35049761-A2300F03-F70A-4D76-A6A9-FA95C2F1ACB2

Q35049761-B6AFED89-5CD0-453F-9791-6A85EFCCFBFB

Q35049761-E0E91211-0F0E-4A9B-A0C4-1C6FBA8A8B98

P2860

Q35049761-038516CA-6DD6-4926-8F82-137E957D474A

Q35049761-1CF8ECE3-68DE-4431-97EA-B786179E8A92

Q35049761-1D00028F-D3C1-426F-BFDA-8DFF61B40B84

Q35049761-2AB7ADC8-48F8-4F91-82EB-C47C45E50F06

Q35049761-3272E61F-6525-4A62-8E19-3901CC384268

Q35049761-41D80BB0-4FEB-40D5-A6B1-C5279DB0C9B0

Q35049761-9B18361A-002C-494B-8F80-4AEFC602D04B

Q35049761-9CADD9CA-A4D5-4475-B0FA-AFD5C4D94B38

Q35049761-A8903A43-84F2-46DE-91D2-C18C272144E6

Q35049761-AA42A74F-88C6-4F2E-B69E-F963E9AF9EFB

P304

Q35049761-81B01C6A-BC77-44A3-9649-05383B9B925F

P31

Q35049761-8AD9EEBA-A2C2-47AD-90DA-E7B9337F8A2F

P356

Q35049761-7B428630-5AB3-412B-9A18-BAA06A95D13D

P407

Q35049761-FA5842DC-50AA-4BCB-8A64-4F56C10EC625

P433

Q35049761-FF1ED140-B232-43A5-BC0C-786FEE6C858A

P478

Q35049761-77FC1A58-D7D0-453B-83BA-34F3268C7FA2

P50

Q35049761-1B8B10EA-3F7A-4129-A134-B6E0B7229563

P577

Q35049761-62C2432F-8180-4A44-B0E2-78460A72C9F4

P5875

Q35049761-CCD0395D-D386-47DD-B41D-B44455D573A0

P698

Q35049761-1601EC4D-9B13-476E-82B5-0FE0DC7998D6

P921

Q35049761-B6410151-14F9-4B71-A1EB-F6EF3B6215E9

P932

Q35049761-22DD3284-AA56-4CB1-89A5-C777E185600A

P356

ARCHPEDIATRICS.2010.163

P1433

JAMA Pediatrics

P1476

Perfluorooctanoic acid, perflu ...... ts from the C8 Health Project.

@en

P2093

Alan M Ducatman

http://www.w3.org/2001/XMLSchema#string

Anoop Shankar

http://www.w3.org/2001/XMLSchema#string

Kyle Steenland

http://www.w3.org/2001/XMLSchema#string

Sarah S Knox

http://www.w3.org/2001/XMLSchema#string

Stephanie J Frisbee

http://www.w3.org/2001/XMLSchema#string

Tony Fletcher

http://www.w3.org/2001/XMLSchema#string

P2860

Community exposure to perfluorooctanoate: relationships between serum concentrations and exposure sources

The C8 health project: design, methods, and participants

Exposure of perfluorinated chemicals through lactation: levels of matched human milk and serum and a temporal trend, 1996-2004, in Sweden

Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000

Perfluorooctane sulfonate (PFOS) and related perfluorinated compounds in human maternal and cord blood samples: assessment of PFOS exposure in a susceptible population during pregnancy.

Perfluorooctanoic acid, a peroxisome-proliferating hypolipidemic agent, dissociates apolipoprotein B48 from lipoprotein particles and decreases secretion of very low density lipoproteins by cultured rat hepatocytes

Serum concentrations of 11 polyfluoroalkyl compounds in the u.s. population: data from the national health and nutrition examination survey (NHANES).

Toxicity and toxicokinetics of perfluorooctanoic acid in humans and animals.

The toxicology of perfluorooctanoate.

Community exposure to perfluorooctanoate: relationships between serum levels and certain health parameters

P304

860-869

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/ARCHPEDIATRICS.2010.163

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

164

http://www.w3.org/2001/XMLSchema#string

P50

David A. Savitz

P577

2010-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

46158391

http://www.w3.org/2001/XMLSchema#string

P698

20819969

http://www.w3.org/2001/XMLSchema#string

P921

P932

3116641

http://www.w3.org/2001/XMLSchema#string